Your browser doesn't support javascript.
loading
Accuracy of HPV testing on self-collected and clinician-collected samples for different screening strategies in African settings: A systematic review and meta-analysis.
Sy, Frithjof; Greuel, Merlin; Winkler, Volker; Bussmann, Hermann; Bärnighausen, Till; Deckert, Andreas.
Afiliação
  • Sy F; Institute of Global Health, University of Heidelberg, Heidelberg, Germany. Electronic address: frithjof.sy@gmail.com.
  • Greuel M; Institute of Global Health, University of Heidelberg, Heidelberg, Germany.
  • Winkler V; Institute of Global Health, University of Heidelberg, Heidelberg, Germany.
  • Bussmann H; Institute of Pathology, Department of Applied Tumor Biology, University of Heidelberg, Heidelberg, Germany.
  • Bärnighausen T; Institute of Global Health, University of Heidelberg, Heidelberg, Germany; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, USA; Institute for Global Health, University College London, London, UK; Africa Health Research Institute, KwaZulu-Natal, South Af
  • Deckert A; Institute of Global Health, University of Heidelberg, Heidelberg, Germany.
Gynecol Oncol ; 166(2): 358-368, 2022 08.
Article em En | MEDLINE | ID: mdl-35781165
ABSTRACT

OBJECTIVES:

Cervical cancer still poses a considerable threat to women in low- and middle-income countries, particularly on the African continent. Self-collection of a vaginal sample promises advantages over the established sampling by clinicians. We aimed to assess the accuracy of self-sampling compared to clinician sampling in order to inform its application in primary care in the African context.

METHODS:

We searched Pubmed, Livivo, Web of Science, Cochrane Library and African Index Medicus on the 07th of February 2022. The eligibility criteria were reporting (i) self-sampling against clinician-sampling, (ii) study location in Africa, (iii) relevant outcome-

measures:

(a) Cohen's kappa (b) sensitivity and specificity of self-sampling tests. We combined Cohen's kappa effects, additionally sensitivity and specificity estimates using random-effects models. The study is registered with PROSPERO (CRD42020218081).

RESULTS:

We included 28 studies in the systematic review and 21 studies in the meta-analysis. Self-sampling was used to test for high-risk HPV infections. Two studies additionally tested for low-risk HPV infections. The pooled Cohen's kappa was 0.66 (95%CI 0.61-0.71). Populations at risk yielded 0.63 (95%CI 0.56-0.71). Target amplification tests based on PCR performed best with a kappa of 0.68 (95%CI 0.63-0.73) compared to isothermal mRNA tests, 0.61 (95%CI 0.51-0.71). Point of care tests performed exceptionally well, 0.73 (95%CI 0.67-0.80). Sensitivities are close to 80% and specificities close to 90% of self-sampling to detect high-risk HPV.

CONCLUSIONS:

Self-sampling agrees moderately to substantially with clinician sampling in the African context. Point of care tests might be particularly suited for application in cervical cancer primary screening in low- and middle-income countries. Populations at risk should get special attention while using self-sampling. Screening protocols should be established.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Infecções por Papillomavirus Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies / Systematic_reviews Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Infecções por Papillomavirus Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies / Systematic_reviews Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2022 Tipo de documento: Article